Study of Patient/tumor/treatment related factors (Anemia, weight loss, muscle strength ect) on treatment toxicities and post treatment outcome
Not Applicable
- Registration Number
- CTRI/2021/11/038031
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Newly diagnosed squamous cell carcinoma patients of head and neck (Oral cavity, Nasopharynx, Oropharynx, Larynx and Hypopharynx), treatment naïve planned for definitive radiotherapy or chemoradiotherapy
2.Age â?? Above 18 years
Exclusion Criteria
1.Head and Neck cancer patients with Distant metastasis
2.Patients with active viral infection- HIV, Hepatitis B/C, COVID-19, active tubercular infection, any other active bacterial infection
3.Patients with abnormal liver or renal function tests
4.Patients with conditions â?? uncontrolled DM/HTN, Walking impairment, History of autoimmune disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the impact of patient specific, tumor and treatment related factors on treatment related acute toxicities (Grade wise) â?? as per RTOG Criteria (skin, mucosal, pharyngeal, laryngeal), as per CTCAE Criteria version 5 (hematological and gastrointestinal)Timepoint: After the completion of 6 weeks of proposed Cancer treatment
- Secondary Outcome Measures
Name Time Method To assess the impact of patient specific, tumor and treatment related factors on oncological outcome in head and neck cancer patients receiving definitive radiotherapy or chemo-radiotherapyTimepoint: After the completion of 6 weeks of proposed Cancer treatment